[go: up one dir, main page]

AR004330A1 - Uso de inhibidores de colinesterasa en el tratamiento de xerostomia - Google Patents

Uso de inhibidores de colinesterasa en el tratamiento de xerostomia

Info

Publication number
AR004330A1
AR004330A1 ARP960105229A ARP960105229A AR004330A1 AR 004330 A1 AR004330 A1 AR 004330A1 AR P960105229 A ARP960105229 A AR P960105229A AR P960105229 A ARP960105229 A AR P960105229A AR 004330 A1 AR004330 A1 AR 004330A1
Authority
AR
Argentina
Prior art keywords
treatment
xerostomy
cholinesterase inhibitors
cholinesterase
inhibitors
Prior art date
Application number
ARP960105229A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR004330A1 publication Critical patent/AR004330A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Se provee el uso de un inhibidor de colinesterasa en la manufactura de un medicamento para administración tópica destinado a su uso en el tratamientode xerostomia.
ARP960105229A 1995-11-29 1996-11-18 Uso de inhibidores de colinesterasa en el tratamiento de xerostomia AR004330A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9504267A SE9504267D0 (sv) 1995-11-29 1995-11-29 New therapeutic use

Publications (1)

Publication Number Publication Date
AR004330A1 true AR004330A1 (es) 1998-11-04

Family

ID=20400405

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960105229A AR004330A1 (es) 1995-11-29 1996-11-18 Uso de inhibidores de colinesterasa en el tratamiento de xerostomia

Country Status (14)

Country Link
US (1) US5962503A (es)
EP (1) EP0866699B1 (es)
JP (1) JP4113257B2 (es)
CN (2) CN1207679A (es)
AR (1) AR004330A1 (es)
AT (1) ATE216235T1 (es)
AU (1) AU718661B2 (es)
DE (1) DE69620786T2 (es)
DK (1) DK0866699T3 (es)
ES (1) ES2175153T3 (es)
PT (1) PT866699E (es)
SE (1) SE9504267D0 (es)
WO (1) WO1997019685A1 (es)
ZA (1) ZA969586B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004534075A (ja) * 2001-06-14 2004-11-11 ノボ　ノルディスク　アクティーゼルスカブ Ｔｆｆダイマーペプチドによる粘膜修復
JP2006070027A (ja) * 2004-08-06 2006-03-16 Dai Ichi Seiyaku Co Ltd 口腔粘膜投与剤
US20060263414A1 (en) * 2005-05-19 2006-11-23 Pauline Pan Confectionery products for the treatment of dry mouth
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
US9161909B2 (en) * 2007-08-24 2015-10-20 Axiomedic Ltd. Adhesive compositions for the treatment of xerostomia
US20090053309A1 (en) * 2007-08-24 2009-02-26 Axiomedic Ltd., Gibraltar Adhesive compositions for the treatment of xerostomia
CN114010575B (zh) * 2021-10-22 2024-06-28 江苏谛奇医药科技有限公司 新斯的明及其衍生物的新制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187165A (en) * 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
SE9103752D0 (sv) * 1991-12-18 1991-12-18 Astra Ab New compounds
US5387614A (en) * 1993-07-27 1995-02-07 University Of Iowa Research Foundation Use of sigma receptor ligands as salivary gland stimulants

Also Published As

Publication number Publication date
CN101380320B (zh) 2010-12-29
WO1997019685A1 (en) 1997-06-05
AU7716096A (en) 1997-06-19
ES2175153T3 (es) 2002-11-16
CN1207679A (zh) 1999-02-10
JP4113257B2 (ja) 2008-07-09
DE69620786T2 (de) 2002-11-21
CN101380320A (zh) 2009-03-11
JP2000508618A (ja) 2000-07-11
DE69620786D1 (de) 2002-05-23
PT866699E (pt) 2002-08-30
US5962503A (en) 1999-10-05
ATE216235T1 (de) 2002-05-15
AU718661B2 (en) 2000-04-20
EP0866699A1 (en) 1998-09-30
EP0866699B1 (en) 2002-04-17
DK0866699T3 (da) 2002-08-12
ZA969586B (en) 1997-05-29
SE9504267D0 (sv) 1995-11-29

Similar Documents

Publication Publication Date Title
ES2157958T3 (es) Uso de venlafaxina o de un compuesto de ariloxipropanamina para la preparacion de un medicamento para el tratamiento de la incontinencia urinaria.
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
MX9706769A (es) Formas de dosificacion farmaceutica que comprenden un inhibidor de la bomba de protones y un agente procinetico.
TR200103493T2 (tr) Metaloproteaz önleyicileri
ATE240334T1 (de) Pyrrolobenzodiazepine
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
MY115662A (en) Novel compounds with analgesic effect
BR0013935A (pt) IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos
ES2177642T3 (es) Uso de ciertos derivados de acido metanobisfosfonico para prevenir el desprendimiento y la migracion de protesis.
IS4923A (is) Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara
FR2735369B1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
SE9601556D0 (sv) New pharmaceutical formulation of a thrombin inhibitor for parenteral use
ES2161292T3 (es) Composicion de higiene oral.
AR004330A1 (es) Uso de inhibidores de colinesterasa en el tratamiento de xerostomia
ES2148493T3 (es) Nuevos compuestos con efecto analgesico y anestesico local.
SE9900070D0 (sv) New use
ES2171743T3 (es) Derivados de amidinas e isotioureas como inhibidores de la enzima sintasa de oxido nitrico.
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
SE9504662D0 (sv) New compounds
ES2188611T3 (es) Empleo de granisetron para el tratamiento de las nauseas y vomitos postoperatorios.
NO20001548D0 (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
UY26648A1 (es) Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada
AR012638A1 (es) Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.